Aberrant regulation of interleukin-12 receptor β2 chain on type 1 cytokine-stimulated T lymphocytes in type 1 diabetes

Immunology

Volumn 114, Issue 2, 2005, Pages 287-293

  Skarsvik, Susanne ^a   Ludvigsson, Johnny ^a   Vaarala, Outi ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

IL 12R; IL 13; T cells; Type 1 diabetes

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 5; PHYTOHEMAGGLUTININ;

ADOLESCENT; ADULT; ARTICLE; CELL POLARITY; CELL STIMULATION; CELL TYPE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL POLARITY; CELLS, CULTURED; CHILD; CYTOKINES; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-11 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MITOGENS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-11; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES; TIME FACTORS;

EID: 13444292009     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2004.02102.x     Document Type: Article

References (22)

1. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Bleackley RC, Power RF. IFN-gamma gene expression in pancreatic islet-infiltrating mononuclear cells correlates with autoimmune diabetes in nonobese diabetic mice. J Immunol 1995; 154:4874-82.
2. Maggi E, Parronchi P, Manetti R et al. Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones. J Immunol 1992; 148:2142-7.
3. Kallmann BA, Huther M, Tubes M, Feldkamp J, Bertrams J, Gries FA, Lampeter EF, Kolb H. Systemic bias of cytokine production toward cell-mediated immune regulation in IDDM and toward humoral immunity in Graves' disease. Diabetes 1997; 46:237-43.
4. Berman MA, Sandborg CI, Wang Z, Imfeld KL, Zaldivar F Jr, Dadufalza V, Buckingham BA. Decreased IL-4 production in new onset type 1 insulin-dependent diabetes mellitus. J Immunol 1996; 157:4690-6.
5. Mayer A, Rharbaoui F, Thivolet C, Orgiazzi J, Madec AM. The relationship between peripheral T cell reactivity to insulin, clinical remissions and cytokine production in type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 1999; 84:2419-24.
6. Halminen M, Simell O, Knip M, Ilonen J. Cytokine expression in unstimulated PBMC of children with type 1 diabetes and subjects positive for diabetes-associated autoantibodies. Scand J Immunol 2001; 53:510-3.
7. Kukreja A, Cost G, Marker J et al. Multiple immuno-regulatory defects in type-1 diabetes. J Clin Invest 2001; 109:131-40.
8. Lohmann T, Laue S, Nietzschmann U, Kapellen TM, Lehmann I, Schroeder S, Paschke R, Kiess W. Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes. Diabetes 2002; 51:2474-80.
9. 4+ T cells. J Immunol 1995; 154:5071-9.
10. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145:3796-806.
11. + T cells can be primed in vitro to produce IL-4. J Immunol 1992; 148:1652-6.
12. Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA 1996; 93:14002-7.
13. Rogge L, Barberis-Maino L, Biffi M, Passini N, Presky DH, Gubler U, Sinigaglia F. Selective expression of an interleukin-12 receptor component by human T helper 1 cells. J Exp Med 1997; 185:825-32.
14. Rogge L, Papi A, Presky DH et al. Antibodies to the IL-12 receptor β2 chain mark human Th1 but not Th2 cells in vitro and in vivo. J Immunol 1999; 162:3926-32.
15. Chomarat P, Banchereau J. Interleukin-4 and interleukin-13: their similarities and discrepancies. Int Rev Immunol 1998; 17:1-52.
16. Szabo SJ, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin (IL)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997; 185:817-24.
17. Karlsson MG, Lawesson SS, Ludvigsson J. Th1-like dominance in high risk first degree relatives of type I diabetic patients. Diabetologia 2000; 43:742-9.
18. Rapoport MJ, Mor A, Vardi P, Ramot Y, Winker R, Hindi A, Bistritzer T. Decreased secretion of Th2 cytokines precedes up-regulated and delayed secretion of Th1 cytokines in activated peripheral blood mononuclear cells from patients with insulin-dependent diabetes mellitus. J Autoimmun 1998; 11:635-42.
19. Upham JW, Lee PT, Holt BJ, Heaton T, Prescott SL, Sharp MJ, Sly PD, Holt PG. Development of interleukin-12-producing capacity throughout childhood. Infect Immun 2002; 70:6583-8.
20. Nissinen R, Leirisalo-Repo M, Tiittanen M, Julkunen H, Hirvonen H, Palosuo T, Vaarala O. CCR3, CCR5, interleukin 4, and interferon-gamma expression on synovial and peripheral T cells and monocytes in patients with rheumatoid arthritis. J Rheumatol 2003; 30:1928-34.
21. Baeten D, Van Damme N, Van den Bosch F, Kruithof E, De Vos M, Mielants H, Veys EM, De Keyser F. Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha. Ann Rheum Dis 2001; 60:750-5.
22. Sadouk M, Vaquero C, de la Tour B, Amor B, Toubert A. Interferon-gamma mRNA expression upon in vitro T lymphocyte activation is decreased in rheumatoid arthritis patients. Clin Immunol Immunopathol 1990; 56:37-45.